Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Operations (2016 - 2025)

Bio-Techne (TECH) has 17 years of Cash from Operations data on record, last reported at 82411000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 2.29% year-over-year to 82411000.0; the TTM value through Dec 2025 reached 249317000.0, down 18.18%, while the annual FY2025 figure was 287556000.0, 3.82% down from the prior year.
  • Cash from Operations reached 82411000.0 in Q4 2025 per TECH's latest filing, up from 27585000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 122020000.0 in Q2 2021 and bottomed at 27585000.0 in Q3 2025.
  • Average Cash from Operations over 5 years is 73654200.0, with a median of 75181000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: skyrocketed 172.42% in 2021, then crashed 56.82% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 100993000.0 in 2021, then crashed by 36.25% to 64384000.0 in 2022, then rose by 29.09% to 83116000.0 in 2023, then increased by 1.48% to 84346000.0 in 2024, then decreased by 2.29% to 82411000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 82411000.0 in Q4 2025, 27585000.0 in Q3 2025, and 98201000.0 in Q2 2025.